Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- mRNA Covid-19 Vaccine Safety in Pregnancy
- Association Between Pre-Existing Respiratory Disease and Its Treatment and Severe COVID-19
- Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination
- Thrombosis and Thrombocytopenia After ChAdOx1 nCoV-19 Vaccination
- Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
- Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin in Primary Cardiovascular Prevention
- Very High Coronary Artery Calcium and Association With CVD Events, Non-CVD Outcomes, and Mortality
- Tocilizumab in Hospitalized Patients With Severe COVID-19 Pneumonia
- IL-6 Receptor Antagonists in Severe COVID-19
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting